New drug trial aims to calm swollen esophagus
NCT ID NCT05485155
First seen Jan 07, 2026 · Last updated May 06, 2026 · Updated 19 times
Summary
This study tests a drug called Zemaira in 15 adults with eosinophilic esophagitis, a condition where the esophagus becomes inflamed and swollen. The goal is to see if Zemaira can reduce inflammation and improve symptoms. Participants receive the drug for 4 weeks and are monitored for side effects and changes in esophageal health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The National Institutes of Health
RECRUITINGBethesda, Maryland, 20892, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.